Skip to main content
. 2022 Aug 11;316:245–253. doi: 10.1016/j.jad.2022.08.017

Table 5.

Comparison of co-morbid clinically significant symptoms (EPDS ≥13 & GAD-7 ≥10) in pregnant and postpartum women across countries.

1 2 3 4 5 6 7 8 9
Pregnant women: χ2(8) = 88.11, p < .001
1. Brazil
2. Chile 0.01
3. Cyprus 26.47⁎⁎⁎ 24.08⁎⁎⁎
4. Greece 34.37⁎⁎⁎ 30.11⁎⁎⁎ 0.01
5. Israel 15.36⁎⁎⁎ 13.80⁎⁎⁎ 1.68 1.79
6. Portugal 17.76⁎⁎⁎ 14.08⁎⁎⁎ 6.31 8.19 1.08
7. Spain 4.65 4.07 12.41⁎⁎⁎ 15.90⁎⁎⁎ 4.84 3.17
8. Turkey 42.05⁎⁎⁎ 33.47⁎⁎⁎ 0.78 0.82 0.55 7.34 16.70⁎⁎⁎
9. UK 3.33 3.09 10.53⁎⁎ 12.76⁎⁎⁎ 3.98 2.17 0.00 11.68⁎⁎⁎



Postpartum women: χ2(8) = 129.96, p < .001
1. Brazil
2. Chile 2.22
3. Cyprus 42.59⁎⁎⁎ 22.68⁎⁎⁎
4. Greece 27.90⁎⁎⁎ 9.95 4.67
5. Israel 64.82⁎⁎⁎ 35.70⁎⁎⁎ 0.59 10.16
6. Portugal 41.57⁎⁎⁎ 13.38⁎⁎⁎ 5.10 0.01 11.45⁎⁎⁎
7. Spain 10.91⁎⁎⁎ 1.58 16.39⁎⁎⁎ 4.91 28.03⁎⁎⁎ 7.22
8. Turkey 56.51⁎⁎⁎ 21.86⁎⁎⁎ 1.77 1.46 5.59 1.69 14.73⁎⁎⁎
9. UK 9.69 1.65 14.32⁎⁎⁎ 3.81 24.50⁎⁎⁎ 5.37 0.02 11.57⁎⁎⁎

Notes: Bonferroni-corrected p-value (.05/36) = .0014. UK = United Kingdom.

⁎⁎

p < .01.

⁎⁎⁎

p < .001.